z-logo
Premium
Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y 1 receptors
Author(s) -
Vigne Paul,
Philippe Breittmayer Jean,
Frelin Christian
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702115
Subject(s) - apyrase , p2y receptor , receptor , p2 receptor , intracellular , purinergic receptor , agonist , adenosine diphosphate , adenosine , biochemistry , atpase , biology , chemistry , enzyme , platelet , platelet aggregation , immunology
1 ADP is a potent agonist of rat and human P2Y 1 purinoceptors. ATP is a weak competitive antagonist. This study analyses the situation in which P2Y 1 receptors are exposed to ATP in the presence of exogenous ecto‐nucleotidases (apyrases) that have high or low ATPase/ADPase activity ratio. 2 Rat brain capillary endothelial cells of the B10 clone express P2Y 1 receptors that couple to intracellular Ca 2+ mobilization. They have low endogenous ecto‐ATPase and ecto‐ADPase activities. 3 ATP did not raise intracellular Ca 2+ in B10 cells. Addition of apyrases III or VII (1 u ml −1 ) to ATP treated cells induced large intracellular Ca 2+ transients. Apyrases had no action in the absence of ATP. 4 A 1 u ml −1 apyrase III solution generated 20 μ M ADP from 0.1 m M ATP within 15 s. This concentration of ADP was sufficient to produce maximal activation of P2Y 1 receptors. 5 ATP was a full agonist of P2Y 1 receptors in the presence of 1 u ml −1 apyrase III. Dose response curves for the apparent actions of ATP were bell shaped in the presence of 0.1 u ml −1 apyrase III. Apyrase III did not alter ADP dose response curves when coincubated with ADP for 15 s. 6 Apyrase VII (1 u ml −1 ) shifted dose response curves for the actions of ADP to larger concentrations. It induced a bell shaped ATP dose response curve. 7 Results suggest that ATPDases prevent P2Y 1 receptor activation by degrading ADP but may contribute to P2Y 1 receptor activation by generating ADP from ATP.British Journal of Pharmacology (1998) 125 , 675–680; doi: 10.1038/sj.bjp.0702115

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom